By Leslie Carol Botha (NaturalNews) Immunologist Charlotte Haug, MD PhD, MSc and Editor-in-Chief, Tidsskrift for Den norske legeforening (The Journal of the Norwegian Medical Association) raises an interesting question that has yet to be considered by the FDA, CDC or the medical community. What happens if other strains of HPV replace strains 16 or 18 […]
Scientists find new vaccine
By Haley Mickey Scientists in Britain have discovered a protein which may be used as a target for a new tuberculosis vaccine. This discovery from Imperial College London could be a first step in the eradication of tuberculosis because though a TB vaccine currently exists — the Bacillus Calmette-Guerin, or BCG vaccine — it is […]
HIV protein unveils vaccine target
An international study headed by a UC Davis scientist describes how a component of a potential HIV vaccine opens like a flower, undergoing one of the most dramatic protein rearrangements yet observed in nature. The finding could reveal new targets for vaccines to prevent HIV infection and AIDS. A paper describing the work was published […]
Research and Markets: Prostate Cancer Vaccines and Therapeutic Antibodies: Pipeline – 2011
DUBLIN — Research and Markets has announced the addition of the “Prostate Cancer Vaccines and Therapeutic Antibodies: Pipeline – 2011” report to their offering. The prostate cancer immunotherapy pipeline is showing rapid development. Currently, there are 30 candidates in the pipeline (16 vaccines and 14 therapeutic antibodies), and one prostate cancer vaccine (Provenge) has recently […]
VRM Projects: PHASE 2 OF WORLDWIDE AUTISM STUDY
Our Autism Study has already reached tens of thousands, and support for the research model has been unanimously positive. We’re now in a good position to build on the groundwork laid in 2010. While we have steadily received invaluable data from those participants involved, the majority of input has come from North America. Let’s all […]
- « Previous Page
- 1
- …
- 56
- 57
- 58
- 59
- 60
- …
- 78
- Next Page »
